NCT06676930 Impact of Artificial Intelligence on Trainee Polyp Miss Rates
| NCT ID | NCT06676930 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Colon Polyps |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-09-10 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2024-09-10 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Based on prior studies, trainee and practicing gastroenterologists miss pre-cancerous polyps (adenomas and serrated polyps) during colonoscopy. The use of computer-aided detection (CADe) systems, a form of artificial intelligence (AI) has been shown to help identify colorectal lesions for practicing gastroenterologists. However, less is known how AI impacts polyp detection for trainees. The investigators are conducting a tandem colonoscopy study wherein a portion of the colon is examined first by the trainee and then the attending physician. For each procedure, randomization will occur which will determine whether or not the trainee will utilize AI for their examination of the colon. At the end of the study, the investigators will determine whether AI helps trainees miss fewer polyps during colonoscopy. The investigators will also conduct interviews with trainees to understand how AI impacts colonoscopy training.
Eligibility Criteria
Inclusion Criteria: * Adult patients referred for screening or surveillance colonoscopy Exclusion Criteria: * Patients referred for polypectomy or diagnostic colonoscopy * Patients with prior right colon surgery * Prolonged insertion time (\>20 minutes) * Poor bowel preparation (Boston Bowel Preparation Score less than or equal to 6)
Contact & Investigator
Rajesh Keswani, MD
PRINCIPAL INVESTIGATOR
Northwestern Medicine
Frequently Asked Questions
Who can join the NCT06676930 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colon Polyps. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06676930 currently recruiting?
Yes, NCT06676930 is actively recruiting participants. Contact the research team at raj-keswani@northwestern.edu for enrollment information.
Where is the NCT06676930 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06676930 clinical trial?
NCT06676930 is sponsored by Northwestern University. The principal investigator is Rajesh Keswani, MD at Northwestern Medicine. The trial plans to enroll 180 participants.